1201080-20-7 Usage
Uses
Used in Pharmaceutical Industry:
Benzoic acid, 3-(acetylamino)-4-ethoxy-, methyl ester is used as a pharmaceutical compound for its potential therapeutic applications due to its anti-inflammatory, analgesic, and anticancer properties.
Used in Drug Development:
In the field of drug development, Benzoic acid, 3-(acetylamino)-4-ethoxy-, methyl ester is used as a candidate for the development of new drugs, given its pharmacological properties and potential therapeutic benefits.
Used in Research and Development:
Benzoic acid, 3-(acetylamino)-4-ethoxy-, methyl ester is utilized in research and development for further exploration of its mechanism of action, potential therapeutic applications, and to understand its full potential in the treatment of various conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1201080-20-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,0,8 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1201080-20:
(9*1)+(8*2)+(7*0)+(6*1)+(5*0)+(4*8)+(3*0)+(2*2)+(1*0)=67
67 % 10 = 7
So 1201080-20-7 is a valid CAS Registry Number.
1201080-20-7Relevant academic research and scientific papers
A new and improved process for N -(4-chloro-3-cyano-7-ethoxyquinolin-6-yl) acetamide
Mao, Yongjun,Liu, Zheng,Yang, Xiaojun,Xia, Xiangfei,Zhang, Rongxia,Li, Jianfeng,Jiang, Xiangrui,Xie, Kai,Zheng, Jin,Zhang, Hui,Suo, Jin,Shen, Jingshan
, p. 1970 - 1973 (2013/02/25)
A new and improved synthetic route to N-(4-chloro-3-cyano-7-ethoxyquinolin- 6-yl)acetamide (1) is described on a kilogram scale. The key step is the basic cyclization of o-[(2-cyanovinyl)amino]benzoate (14) in tBuONa/ tBuOH system to give the 3-cyano-4-hydroxyquinoline (7). The final product 1 is obtained with 49% overall yield (seven steps) and 98.9% purity (HPLC), which makes it a cost-effective and commercially friendly process for scale-up operations.
Synthesis of n-(3-cyano-7-ethoxy-1,4-dihydro-4-oxoquinolin-6-yl)acetamide
Zhang, Qiang,Mao, Yongjun,Liu, Zheng,Xie, Kai,Zhu, Yi,Wei, Yabing,Jiang, Xiangrui,Shen, Jingshan
, p. 2851 - 2856 (2012/02/02)
New route for the preparation of N-(3-cyano-7-ethoxy-1,4-dihydro-4- oxoquinolin-6-yl)acetamide (1), a key intermediate for the synthesis of selective EGFR kinase inhibitors, was described.
